The FDA has permitted two synthetic formulations of THC for treating precise situations: nabilone and dronabinol. THC binds to cannabinoid receptors CB1 and CB2, that are integral elements of the endogenous cannabinoid procedure. Whilst THC displays a weaker binding affinity for CB2 rece